Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-27 @ 11:49 PM
Study NCT ID:
NCT00460850
Status:
TERMINATED
Last Update Posted:
2008-06-30
First Post:
2007-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML20135
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Clinical Trials, Study Director
Old Organization:
Hoffmann-La Roche